Neurodegeneration in Multiple Sclerosis

Neurodegeneration in Multiple Sclerosis
Author: M. Filippi
Publisher: Springer Science & Business Media
Total Pages: 233
Release: 2008-02-01
Genre: Medical
ISBN: 8847003911

Written by world-renowned scientists, the volume provides a state-of-the-art on the most recent MRI techniques related to MS, and it is an indispensable tool for all those working in this field. The context in which this book exists is that there is an increasing perception that modern MR methodologies should be more extensively employed in clinical trials to derive innovative information.

The Neurobiology of Multiple Sclerosis

The Neurobiology of Multiple Sclerosis
Author:
Publisher: Academic Press
Total Pages: 759
Release: 2007-06-07
Genre: Science
ISBN: 0080544274

Multiple sclerosis (MS) is an immune-mediated neurodegenerative disorder of the human central nervous system (CNS) which usually affects young adults with certain genetic backgrounds who are then exposed to certain precipitating environmental antigen(s). Despite major advances of the past two decades in understanding the pathophysiology of MS, and in spite of the introduction of new immunomodulatory and immuno-suppressive agents which may slow down disease progression and delay the onset of disability, the “cause and the “cure for MS remain elusive. This volume of International Review of Neurobiology focuses on MS and related disorders. The volume can be divided into various sections with the main emphasis on MS pathogenesis, clinical features and epidemiology, neuroimaging, and treatment. The ultimate goal of this book is to encourage further research into the pathogenesis of this elusive disease.

White Matter Diseases

White Matter Diseases
Author: Massimo Filippi
Publisher: Springer Nature
Total Pages: 215
Release: 2020-02-13
Genre: Medical
ISBN: 303038621X

This book provides cutting-edge information on the epidemiology, etiopathogenesis, clinical manifestations, diagnostic procedures and treatment approaches for the main white matter (WM) disorders of the central nervous system (CNS). WM lesions are associated with many neurological conditions, and with aging. The diagnostic work-up of neurological diseases characterized by the presence of these lesions has changed dramatically over the past few years. This is mainly due on the one hand to the discovery of specific pathogenetic factors in some of these conditions, and on the order to the optimized use of diagnostic tools. All of this has resulted in new diagnostic algorithms, and in the identification of new neurological conditions. The book offers neurologists essential guidance in the diagnosis and treatment of the most frequent WM conditions, promoting their correct and cost-saving diagnosis and management. By integrating neurological, laboratory and imaging concepts with the demands of accurate diagnosis, this reference guide provides a state-of-the-art overview of the current state of knowledge on these conditions, as well as practical guidelines for their diagnosis and treatment.

Mechanisms of Neurodegeneration in Multiple Sclerosis

Mechanisms of Neurodegeneration in Multiple Sclerosis
Author: Shuo Li
Publisher:
Total Pages: 180
Release: 2015
Genre: Hemoglobin
ISBN:

Multiple sclerosis (MS) is a complicated inflammatory neurodegenerative disease of the central nervous system. Previous studies have demonstrated mitochondrial dysfunction in MS cortical pathology. In the present study, we showed that neuronal mitochondrial metabolite NAA, an indication of neuronal mitochondrial dysfunction, was decreased in MS gray matter. Decreased NAA was correlated with decreased acetate in adjacent white matter for the synthesis of myelin lipids. This suggested that one potential mechanism to reduce demyelination in MS was to restore neuronal mitochondrial function. In neuronal cell cultures, we observed that unexpected expression of neuronal hemoglobin increased cellular glycolysis rates, mitochondrial respiration rates and complex V levels. Hemoglobin alleviated respiration inhibition by excess NO. Neuronal hemoglobin interacted with nNOS in different brain regions responsible for learning and memory. Confocal microscopy specified the interaction between hemoglobin and nNOS to neuronal cell body, neurites, and synapses, which indicated that hemoglobin might regulate synaptic transmission by NO-mediated pathway. Additionally, hemoglobin levels were affected by conditions mimicking MS gray matter pathology in primary neurons. These findings showed implication of developing neuroprotective therapies for MS by increasing neuronal hemoglobin levels. The regulation between mitochondrial dysfunction and demyelination is reciprocal. Demyelination results in increased levels of free MBP in the lesion areas and the CSF of MS patients. In our SH-SY5Y neuroblastoma cell cultures, free MBP led to PS translocation to outer leaflet of plasma membrane, which might be a signal for microglial activation. Free MBP also decreased mitochondrial membrane potential in neuroblastoma cells, which might accumulate mitochondrial stress for mitochondrial dysfunction.

Mechanisms Underlying Neurodegeneration in Multiple Sclerosis

Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
Author: Lisa Christine Golden
Publisher:
Total Pages: 135
Release: 2021
Genre:
ISBN:

Like most autoimmune diseases, multiple sclerosis (MS), is more prevalent in women than men, thought to be due to more robust immune responses in women. The effects of sex hormones on the immune response have been extensively studied by our lab and others, but effects of sex chromosomes are widely unknown. Sex chromosomes can elicit gene expression differences between males and females via expression of Y genes, X gene dosage effects, or parent-of-origin differences in DNA methylation of X genes, also called parental imprinting. We previously showed that sex chromosomes modulate immune responses in the animal model of MS experimental autoimmune encephalomyelitis (EAE), however, the mechanisms remained unknown. Chapter 2 of this dissertation identified parent-of-origin differences in DNA methylation of X chromosome genes as a mechanism by which sex chromosomes alter gene expression in immune cells. Through a series of RNA sequencing experiments using the "four core genotypes" model, we discovered a cluster of X genes with higher expression in XY than XX genotypes in CD4+ T lymphocytes. Additionally, DNA methylation studies in X monosomic mice revealed parent-of-origin differences in DNA methylation in which the paternal X is hypermethylated compared to the maternal X and autosomes, which is consistent with higher expression of X genes in XY compared to XX. This work demonstrated how parental imprinting of X chromosome genes can lead to sex differences in gene expression during immune responses. While women are more susceptible to MS, disability progression tends to be worse in men, thought to be due to a more neurodegenerative response to immune attack. This identifies males as a superior target for understanding mechanisms of neurodegeneration. In Chapter 3 of this dissertation, I take a cell-specific and region-specific gene expression approach to investigate the neurodegenerative response in the hippocampus during injury. Through transcriptomics studies in hippocampal astrocytes, I found upregulated expression of genes involved in MHC class I (MHC I) signaling. Since MHC I has an important role in synaptic plasticity, I hypothesize that astrocyte MHC I signals to microglia and neurons to induce aberrant synaptic pruning in adult mice with disease (EAE). I will test this hypothesis with time- and cell-specific conditional knock out of B2m to reduce MHC I cell surface expression in astrocytes during EAE. Additional studies utilizing gonadectomy will determine the effects of sex hormones on MHC I gene expression. Together, these projects seek to fundamentally understand complex mechanisms in MS susceptibility and progression, and how sex affects these aspects of disease. Further understanding of these mechanisms may lead to identifying natural disease modifiers and new translatable targets for neuroinflammatory therapeutics.

Multiple Sclerosis Therapeutics

Multiple Sclerosis Therapeutics
Author: Richard Rudick
Publisher: CRC Press
Total Pages: 598
Release: 1999-09-01
Genre: Medical
ISBN: 9780415805827

This textbook examines the most important aspects of multiple sclerosis that impact on clinical trial design, on the development of new disease therapies and on patient care. The international team of contributors discuss the clinical course of multiple sclerosis, its clinical heterogeneity, the presence of subclinical disease activity which occurs during the early stages of the disease. Multiple sclerosis presents clinical challenges: from unexpected and irregular relapses to profressive deterioration.

Multiple Sclerosis

Multiple Sclerosis
Author: Alireza Minagar
Publisher: Academic Press
Total Pages: 540
Release: 2015-11-09
Genre: Science
ISBN: 0128010053

Multiple Sclerosis: A Mechanistic View provides a unique view of the pathophysiology of multiple sclerosis (MS) and related disorders. As the only book on the market to focus on the mechanisms of MS rather than focusing on the clinical features and treatment of the disease, it describes the role of genetic and environmental factors in the pathogenesis of MS, the role of specific cells in the pathophysiology of the disease, and the pathophysiology of inflammatory and neurodegenerative disorders related to MS. The book provides discussion of neurodegeneration and neuroregeneration, two critical emerging areas of research, as well as detailed discussion of the mechanisms of action of the approved and investigational drugs for treatment of MS and the emerging role of magnetic resonance spectroscopy (MRI) in investigations into MS. It is the only book on the market to offer comprehensive coverage of the known mechanisms of MS and related diseases, and contains contributions from physicians and researchers who are worldwide experts in the field of study. Focuses on the pathophysiologic mechanisms of multiple sclerosis and the mechanisms of action in agents for the treatment of MS Discusses the roles of neurodegeneration and neuroregeneration in MS and related diseases Authored and edited by international leaders in the field of MS research

Cerebral Cortex

Cerebral Cortex
Author: Deepak N. Pandya
Publisher: Oxford University Press, USA
Total Pages: 481
Release: 2015
Genre: Medical
ISBN: 0195385152

This unique book provides a new view of the organization of the cerebral cortex. It explores the underlying principle of the organization of the cerebral cortex using the dual nature of the origin of the cerebral cortex. Cerebral Cortex provides a different way of understanding the current behavioral studies, neuroimaging observations, and promises a new approach to future studies.

Multiple Sclerosis

Multiple Sclerosis
Author: Institute of Medicine
Publisher: National Academies Press
Total Pages: 457
Release: 2001-08-10
Genre: Medical
ISBN: 0309072859

Multiple sclerosis is a chronic and often disabling disease of the nervous system, affecting about 1 million people worldwide. Even though it has been known for over a hundred years, no cause or cure has yet been discovered-but now there is hope. New therapies have been shown to slow the disease progress in some patients, and the pace of discoveries about the cellular machinery of the brain and spinal cord has accelerated. This book presents a comprehensive overview of multiple sclerosis today, as researchers seek to understand its processes, develop therapies that will slow or halt the disease and perhaps repair damage, offer relief for specific symptoms, and improve the abilities of MS patients to function in their daily lives. The panel reviews existing knowledge and identifies key research questions, focusing on: Research strategies that have the greatest potential to understand the biological mechanisms of recovery and to translate findings into specific strategies for therapy. How people adapt to MS and the research needed to improve the lives of people with MS. Management of disease symptoms (cognitive impairment, depression, spasticity, vision problems, and others). The committee also discusses ways to build and financially support the MS research enterprise, including a look at challenges inherent in designing clinical trials. This book will be important to MS researchers, research funders, health care advocates for MS research and treatment, and interested patients and their families.